5 Hrs
Source:
المشهد
Lilly Weight Loss Results
Eli Lilly announced promising results from two trials of obesity drugs at ObesityWeek 2026, while noting that the full results have not yet been published. The combination drug “Elora TZP” reduced weight by an average of 23.3% among adults with type 2 diabetes after 48 weeks and lowered average HbA1c by 2.9%; 77% of participants also achieved normal blood sugar levels. In a trial involving adolescents aged 12 to 18, Zepbound reduced BMI by an average of 21.4% after 72 weeks, with improvements in weight-related quality of life.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)